openPR Logo
Press release

Anti Malarial Drugs Market to Reach US$ 1333.16 Mn by 2030 with 4.3% CAGR

01-10-2025 11:43 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: MAXIMIZE MARKET RESEARCH PVT. LTD.

Anti-Malarial Drugs Market

Anti-Malarial Drugs Market

The global anti-malarial drugs market is projected to experience significant growth due to advancements in research and rising awareness about malaria prevention. The market was valued at US $ 992.87 Mn. in 2023 and is expected to grow at a CAGR of 4.3% from 2024 to 2030, reaching nearly US $ 1333.16 Mn. by 2030.

๐†๐ž๐ญ ๐š ๐œ๐ฅ๐จ๐ฌ๐ž๐ซ ๐ฅ๐จ๐จ๐ค ๐š๐ญ ๐ญ๐ก๐ž ๐ ๐š๐ฆ๐ž-๐œ๐ก๐š๐ง๐ ๐ข๐ง๐  ๐ฉ๐ซ๐จ๐๐ฎ๐œ๐ญ๐ฌ ๐๐ซ๐ข๐ฏ๐ข๐ง๐  ๐ฌ๐ฎ๐œ๐œ๐ž๐ฌ๐ฌ :https://www.maximizemarketresearch.com/request-sample/24938/

๐€๐ง๐ญ๐ข-๐Œ๐š๐ฅ๐š๐ซ๐ข๐š๐ฅ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐•๐ข๐ž๐ญ๐ง๐š๐ฆ

Vietnam's anti-malarial drugs market has shown steady growth due to government initiatives targeting malaria elimination. Collaborative efforts with global organizations such as the ๐–๐จ๐ซ๐ฅ๐ ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐Ž๐ซ๐ ๐š๐ง๐ข๐ณ๐š๐ญ๐ข๐จ๐ง (๐–๐‡๐Ž) have led to a reduction in malaria cases. Additionally, partnerships between ๐ฅ๐จ๐œ๐š๐ฅ ๐ก๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ž๐ซ๐ฌ and pharmaceutical companies are driving market growth.

๐€๐ง๐ญ๐ข-๐Œ๐š๐ฅ๐š๐ซ๐ข๐š๐ฅ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ ๐“๐ซ๐ž๐ง๐๐ฌ ๐ข๐ง ๐“๐ก๐š๐ข๐ฅ๐š๐ง๐

Thailand is focusing on innovative treatment options to combat drug-resistant malaria strains. Recent mergers, such as the collaboration between ๐๐จ๐ฏ๐š๐ซ๐ญ๐ข๐ฌ and ๐ฅ๐จ๐œ๐š๐ฅ ๐๐ข๐ฌ๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐จ๐ซ๐ฌ, are expected to streamline drug availability. Thailand's National Malaria Elimination Strategy 2024-2030 is a key driver for market expansion.

๐€๐ง๐ญ๐ข-๐Œ๐š๐ฅ๐š๐ซ๐ข๐š๐ฅ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‚๐จ๐ง๐ฌ๐จ๐ฅ๐ข๐๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐‰๐š๐ฉ๐š๐ง

Japan's pharmaceutical sector has been investing in advanced research to develop next-generation anti-malarial drugs. Recent investments by ๐“๐š๐ค๐ž๐๐š ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ๐ฌ into malaria drug trials underline the country's commitment to tackling global health challenges. Strategic collaborations with regional healthcare providers also contribute to market consolidation.

๐”๐ง๐ฅ๐จ๐œ๐ค ๐œ๐ซ๐ข๐ญ๐ข๐œ๐š๐ฅ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐›๐ฒ ๐ž๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ข๐ง๐  ๐ญ๐ก๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐ฏ๐ข๐š ๐ญ๐ก๐ž ๐ฅ๐ข๐ง๐ค @https://www.maximizemarketresearch.com/request-sample/24938/

๐€๐ง๐ญ๐ข-๐Œ๐š๐ฅ๐š๐ซ๐ข๐š๐ฅ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐”๐ฉ๐๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐‚๐ก๐ข๐ง๐š

China has made remarkable progress in eliminating malaria, as highlighted by its certification from WHO in 2021. The market is witnessing a pivot toward manufacturing and exporting anti-malarial drugs. Companies like ๐’๐ก๐š๐ง๐ ๐ก๐š๐ข ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ๐ฌ have increased their R&D investments, aiming for innovative treatments that can cater to global markets.

๐€๐ง๐ญ๐ข-๐Œ๐š๐ฅ๐š๐ซ๐ข๐š๐ฅ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ ๐ข๐ง ๐’๐จ๐ฎ๐ญ๐ก ๐Š๐จ๐ซ๐ž๐š

South Korea's market is characterized by technological advancements in drug formulation. Companies like ๐‚๐ž๐ฅ๐ฅ๐ญ๐ซ๐ข๐จ๐ง and ๐’๐š๐ฆ๐ฌ๐ฎ๐ง๐  ๐๐ข๐จ๐ฅ๐จ๐ ๐ข๐œ๐ฌ are focusing on biosimilar development for anti-malarial treatments. Collaborations with African healthcare initiatives have also opened new opportunities for South Korean manufacturers.

๐€๐ง๐ญ๐ข-๐Œ๐š๐ฅ๐š๐ซ๐ข๐š๐ฅ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐’๐ข๐ง๐ ๐š๐ฉ๐จ๐ซ๐ž

Singapore is emerging as a hub for clinical trials and pharmaceutical innovation. Recent partnerships between ๐†๐ฅ๐š๐ฑ๐จ๐’๐ฆ๐ข๐ญ๐ก๐Š๐ฅ๐ข๐ง๐ž (๐†๐’๐Š) and local research centers have enhanced drug development processes. The government's strong focus on healthcare innovation further bolsters the market outlook.

๐€๐ง๐ญ๐ข-๐Œ๐š๐ฅ๐š๐ซ๐ข๐š๐ฅ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐”๐ฉ๐๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐ญ๐ก๐ž ๐”๐ง๐ข๐ญ๐ž๐ ๐’๐ญ๐š๐ญ๐ž๐ฌ

The US remains one of the leading markets for anti-malarial drugs due to significant investments in R&D and robust healthcare infrastructure. Companies such as ๐๐Ÿ๐ข๐ณ๐ž๐ซ and ๐Œ๐ž๐ซ๐œ๐ค have made strides in malaria vaccine research, complementing the drug market. Strategic acquisitions, such as GSK's recent partnership with US-based biotech firms, underscore consolidation trends.

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐๐š๐ญ๐š ๐š๐ง๐ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐›๐ฒ ๐ฏ๐ข๐ž๐ฐ๐ข๐ง๐  ๐ญ๐ก๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž @https://www.maximizemarketresearch.com/request-sample/24938/

๐€๐ง๐ญ๐ข-๐Œ๐š๐ฅ๐š๐ซ๐ข๐š๐ฅ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‚๐จ๐ง๐ฌ๐จ๐ฅ๐ข๐๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐„๐ฎ๐ซ๐จ๐ฉ๐ž

Europe is focusing on sustainable manufacturing practices in the anti-malarial drugs market. Companies like ๐’๐š๐ง๐จ๐Ÿ๐ข and ๐๐š๐ฒ๐ž๐ซ have intensified their efforts in producing affordable treatments. The region also benefits from initiatives like the European & Developing Countries Clinical Trials Partnership (EDCTP), fostering cross-border research collaborations.

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง:

๐›๐ฒ ๐ƒ๐ซ๐ฎ๐  ๐“๐ฒ๐ฉ๐ž

Quinine
Chloroquine
Amodiaquine
Pyrimethamine
Others

A medication called quinine is used to treat babesiosis and malaria. When artesunate is unavailable, quinine is used to treat malaria because Plasmodium falciparum is resistant to chloroquine. Patients with malaria can have fewer Plasmodium parasites in their blood by taking artemisinin. Artemisinin side effects include liver problems, tremors, nausea, vomiting, and skin rashes.

๐›๐ฒ ๐Œ๐š๐ฅ๐š๐ซ๐ข๐š ๐“๐ฒ๐ฉ๐ž

Plasmodium Falciparum
Plasmodium Vivax
Plasmodium Malariae
Plasmodium Ovale

The two most dangerous species of malaria are Plasmodium falciparum and Plasmodium vivax. The most prevalent malaria parasite in South Africa, Plasmodium falciparum, is also the one that kills the most people worldwide. Plasmodium falciparum grows rapidly, resulting in blocked blood arteries and significant blood loss. Asia Pacific is where Plasmodium vivax is primarily found. Each year, Plasmodium vivax causes malaria in 19-50 million people.

๐›๐ฒ ๐Œ๐ž๐œ๐ก๐š๐ง๐ข๐ฌ๐ฆ ๐จ๐Ÿ ๐€๐œ๐ญ๐ข๐จ๐ง

Resistance
Prevention

๐›๐ฒ ๐ƒ๐ข๐ฌ๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ข๐จ๐ง ๐‚๐ก๐š๐ง๐ง๐ž๐ฅ

Hospitals & Retail Pharmacy
E-Commerce
Others

๐†๐ž๐ญ ๐š ๐๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐š๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ:https://www.maximizemarketresearch.com/market-report/global-anti-malarial-drugs-market/24938/

๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ:

1. Mylan Labs
2. Cipla
3. GlaxoSmithKline
4. Novartis
5. Roche
6. Bayer AG
7. Lincoln Pharmaceuticals
8. Strides Pharma Science
9. Glenmark Pharmaceuticals
10.Alliance Pharmaceuticals
11.F. Hoffmann-La Roche AG
12.Alvizia Healthcare Pvt. Ltd.
13.Ipca Laboratories Ltd.
14.Merck & Co., Inc
15.Sun Pharmaceutical Industries Ltd.
16.Zydus Cadila.
17.Ranbaxy Laboratories

๐‚๐ก๐ž๐œ๐ค ๐จ๐ฎ๐ญ ๐จ๐ฎ๐ซ ๐ญ๐ซ๐ž๐ง๐๐ข๐ง๐  ๐ฌ๐ญ๐ฎ๐๐ข๐ž๐ฌ ๐ญ๐จ ๐ฎ๐ง๐๐ž๐ซ๐ฌ๐ญ๐š๐ง๐ ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐ฌ๐ก๐ข๐Ÿ๐ญ๐ฌ :

โ™ฆ Thin Boiling Starch Market https://www.maximizemarketresearch.com/market-report/thin-boiling-starch-market/147120/

โ™ฆ Wireless Keyboard Market https://www.maximizemarketresearch.com/market-report/global-wireless-keyboard-market/3701/

โ™ฆ Global Cesium Market https://www.maximizemarketresearch.com/market-report/global-cesium-market/89395/

โ™ฆ Industrial Palletizing Robots Market https://www.maximizemarketresearch.com/market-report/industrial-palletizing-robots-market/77409/

โ™ฆ Operational Technology Market https://www.maximizemarketresearch.com/market-report/operational-technology-market/171620/

โ™ฆ Global Fall Detection System Market https://www.maximizemarketresearch.com/market-report/global-fall-detection-system-market/25573/

โ™ฆ Global Conductive Inks Market https://www.maximizemarketresearch.com/market-report/global-conductive-inks-market/33202/

โ™ฆ Enterprise Risk Management Market https://www.maximizemarketresearch.com/market-report/global-enterprise-risk-management-market/39991/

โ™ฆ Global Soy Milk Market https://www.maximizemarketresearch.com/market-report/global-soy-milk-market/77593/

โ™ฆ Ductless HVAC System Market https://www.maximizemarketresearch.com/market-report/global-ductless-hvac-system-market/28305/

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:

MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
+91 9607365656
sales@maximizemarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti Malarial Drugs Market to Reach US$ 1333.16 Mn by 2030 with 4.3% CAGR here

News-ID: 3810518 • Views: โ€ฆ

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

Bangladesh Ceramics Tiles Market to Surpass USD 2.1 Billion by 2030, Fueled by a Robust 13.71% CAGR
09-05-2025 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Bangladesh Ceramics Tiles Market to Surpass USD 2.1 Billion by 2030, Fueled by a โ€ฆ
Bangladesh Ceramics Tiles Market size was valued at USD 882.56 Million in 2023 and the total Bangladesh Ceramics Tiles Market revenue is expected to grow at a CAGR of 13.71 % from 2024 to 2030, reaching nearly USD 2169.38 Million. Bangladesh Ceramics Tiles Market Overview: The Bangladesh ceramics tiles market is a vital component of the country's construction and building materials industry, driven by rapid urbanization, infrastructure development, and rising disposable incomes.โ€ฆ
Furfural Market to Reach Nearly USD 1 Trillion by 2030, Propelled by a 6.8% CAGR
09-05-2025 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Furfural Market to Reach Nearly USD 1 Trillion by 2030, Propelled by a 6.8% CAGR
Furfural Market size was valued at USD 630.2Mn in 2023. The Furfural Market revenue is growing at a CAGR of 6.8 % from 2023 to 2029, reaching nearly USD 998.30 Bn by 2030. Furfural Market Overview: The furfural market is centered around an organic compound derived primarily from agricultural byproducts such as corn cobs, sugarcane bagasse, and rice husks through a process of acid hydrolysis. As one of the oldest renewable chemicals,โ€ฆ
Chemical Protective Clothing Market Valued at USD 1.57 Bn in 2024, Projected to Grow at a 5.59% CAGR Through 2032
09-05-2025 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Chemical Protective Clothing Market Valued at USD 1.57 Bn in 2024, Projected to โ€ฆ
Chemical Protective Clothing Market size was valued at USD 1.57 Billion in 2024 and the total Chemical Protective Clothing revenue is expected to grow at a CAGR of 5.59% from 2025 to 2032, reaching nearly USD 2.42 Billion. Chemical Protective Clothing Market Overview: The Chemical Protective Clothing (CPC) market comprises garments and accessories specifically designed to shield workers from exposure to hazardous chemicals, liquids, and particulate matter across a wide range ofโ€ฆ
Prefabricated Homes Market Valued at USD 18.58 Bn in 2024, Poised for 6.19% CAGR Growth to 2032
09-05-2025 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Prefabricated Homes Market Valued at USD 18.58 Bn in 2024, Poised for 6.19% CAGR โ€ฆ
Prefabricated Homes Market size was valued at USD 18.58 Billion in 2024 and the total Prefabricated Homes revenue is expected to grow at a CAGR of 6.19% from 2025 to 2032, reaching nearly USD 30.04 Billion. Prefabricated Homes Market Overview: The prefabricated homes market, also known as modular or off-site construction, involves the manufacturing of building components in a controlled factory environment before their assembly at the final location. This method revolutionizesโ€ฆ

All 5 Releases


More Releases for Plasmodium

08-20-2025 | Health & Medicine
Exactitude Consultancy
Plasmodium Vivax Malaria Market Outlook 2025-2034, Global Trends and Forecast An โ€ฆ
Plasmodium vivax is one of the most common species of malaria parasites, responsible for a large proportion of malaria cases worldwide. Unlike Plasmodium falciparum, which causes more severe malaria, P. vivax malaria can still lead to significant morbidity and mortality if not properly managed. As global efforts to combat malaria intensify, the Plasmodium vivax malaria market is experiencing notable growth, driven by advancements in treatment options, diagnostics, and vaccine development.โ€ฆ
10-20-2022 | Business, Economy, Finances, B โ€ฆ
Stratagem Market Insights
Highlights On Future Development in Plasmodium Falciparum Diagnostics Market 202 โ€ฆ
The new research study that is being offered here is an excellent compilation of numerous analyses of important elements of the Global Plasmodium Falciparum Diagnostics Market. It clarifies how the Plasmodium Falciparum Diagnostics market is anticipated to expand globally over the course of the projected period 2022-2030. The strengths and weaknesses of the global Plasmodium Falciparum Diagnostics market and the many companies operating therein are thoroughly explained using SWOT analysisโ€ฆ
06-01-2021 | Health & Medicine
Orion Market Reports
Malaria Diagnostics Market 2021 Growth, COVID Impact, Trends Analysis Report 202 โ€ฆ
The Malaria Diagnostics Market is expected to register a CAGR of 4% over the forecast period 2021-2027. Malaria is a parasitic infection and can be very fatal if not treated. The plague is spread by an infected female Anopheles mosquito bite. The bite transfers the Plasmodium parasite to the human body. There are also many types of Plasmodium parasites such as Plasmodium vivax, Plasmodium falciparum, Plasmodium malariae, Plasmodium ovale, and Plasmodiumโ€ฆ
02-16-2021 | Health & Medicine
KEY ORGANICS LTD
NSTDA-BIOTEC selects Key Organics BIONET Fragment Library to identify new non-py โ€ฆ
The National Center for Genetic Engineering and Biotechnology (BIOTEC) is a research center under the umbrella of the National Science and Technology Development Agency (NSTDA), Ministry of Higher Education, Science, Research and Innovation of Thailand. The center was founded on 20 September 1983 and became a member of NSTDA in 1991. BIOTECโ€™s Health and Medicine program focuses its research and development to advance knowledge on neglected diseases such as malaria. Malariaโ€ฆ
11-05-2018 | Health & Medicine
Allied Market Research
Anti-Malarial Drug Market Size , share and growth with top key players GlaxoSmit โ€ฆ
The global anti-malarial drugs market is gradually developing due to the surge in prevalence rate of malaria globally. Favorable government regulations, development of multi-drug resistance (MDR), and increase in research, development, and innovation in terms of anti-malaria therapeutics is anticipated to supplement market growth. However, possible side effects of anti-malaria drugs such as anxiety, dizziness insomnia, and others impede the growth of this market. Anti-malarial drugs are medications used for theโ€ฆ
07-05-2017 | Health & Medicine
Global Antimalarial Drug Market
Outlook on Global Antimalarial Drug Market Size, Status and Forecast 2022 - Baye โ€ฆ
ResearchMoz added Latest Research Report titled " Global Antimalarial Drug Market Size, Status and Forecast 2022 " to it's Large Report database. This report studies the global Antimalarial Drug market, analyzes and researches the Antimalarial Drug development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Pfizer GlaxoSmithKline Ranbaxy Laboratories Ipca Laboratories Ltd Zydus Cadila Merck KGaA Novartis AG Alvizia Health Care Bayer Roche Request for Sampleโ€ฆ